Silence Therapeutics Plc
(OTC) SLNCF
Silence Therapeutics Plc Financials at a Glance
Market Cap
$283.40M
Revenue (TTM)
$559.00K
Net Income (TTM)
$88.61M
EPS (TTM)
$-0.63
P/E Ratio
-3.20
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Price
$2.00
Volume
1,200
Open
$2.00
Price
$2.00
Volume
1,200
Open
$2.00
Previous Close
$2.00
Daily Range
$2.00 - $2.00
52-Week Range
$0.50 - $2.25
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Price
$2.00
Volume
1,200
Open
$2.00
Previous Close
$2.00
Daily Range
$2.00 - $2.00
52-Week Range
$0.50 - $2.25
SLNCF News
SLNCF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silence Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
88
CEO
Iain Gladstone Ross
Website
www.silence-therapeutics.comHeadquarters
London, W14 8TH, GB
SLNCF Financials
Key Financial Metrics (TTM)
Gross Margin
62%
Operating Margin
-163%
Net Income Margin
-159%
Return on Equity
0%
Return on Capital
-77%
Return on Assets
-67%
Earnings Yield
-31.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$283.40M
Shares Outstanding
141.70M
Volume
1.20K
Short Interest
0.00%
Avg. Volume
155.167
Financials (TTM)
Gross Profit
$344.00K
Operating Income
$89.75M
EBITDA
$60.66M
Operating Cash Flow
$62.27M
Capital Expenditure
$55.00K
Free Cash Flow
$62.33M
Cash & ST Invst.
$85.11M
Total Debt
$160.00K
Silence Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$34.00K
-99.9%
Gross Profit
$22.00K
-99.9%
Gross Margin
64.71%
N/A
Market Cap
$283.40M
N/A
Market Cap/Employee
$2.44M
N/A
Employees
116
N/A
Net Income
$11.77M
-183.0%
EBITDA
$9.29M
-229.2%
Quarterly Fundamentals
Net Cash
$85.27M
-42.1%
Accounts Receivable
$18.27M
-32.1%
Inventory
$0.00
N/A
Long Term Debt
$71.00K
N/A
Short Term Debt
$89.00K
-176.1%
Return on Assets
-67.42%
N/A
Return on Invested Capital
-77.30%
N/A
Free Cash Flow
$17.34M
+30.4%
Operating Cash Flow
$17.29M
+30.5%